Elan signs drugs deal with Eli Lilly

ELAN has signed a deal with Eli Lilly to manufacture the international drug giant's drugs at its Athlone site.

Elan will use spare capacity in Athlone to make tablets aimed at treating depression and incontinence.

"This agreement represents a significant milestone for Elan, as it is our first large-scale manufacturing agreement with a leading pharmaceutical company," said Elan chief executive Kelly Martin.